Dr. Fanale on Clinical Trials for T-Cell Lymphoma

The Importance of Clinical Trials | T-Cell Leukemia Lymphoma FoundationПодробнее

Dr. Michelle Fanale on Frontline Brentuximab in Subtypes of LymphomaПодробнее

Understanding Clinical Trials for Anaplastic Large Cell Lymphoma with Dr. Niloufer KhanПодробнее

Patient Selection for Newly Approved Agents in T-Cell LymphomaПодробнее

Cutaneous T-Cell Lymphoma with Barbara Pro, MD | Everything You Need to Know about Blood CancerПодробнее

New Clinical Trials for Diffuse Large B-Cell and T-Cell Lymphomas with Dr. Praveen Ramakrishnan, M.DПодробнее

Understanding Clinical Trials for Peripheral T-Cell Lymphoma with Dr. Pamela Blair AllenПодробнее

Dr. Fanale on Challenges Facing Treatments in T-Cell LymphomaПодробнее

Dr. Fanale Discusses Brentuximab Vedotin in CD30-Positive LymphomasПодробнее

Accessing clinical trials in T Cell LymphomaПодробнее

Upcoming trials and agents in T-cell lymphomaПодробнее

Overview of the LUMIERE clinical trial in peripheral T-cell lymphomaПодробнее

Categorizing subsets of T-cell lymphoma to improve trial design and treatment approachesПодробнее

EHA 18: Rituximab for b-cell lymphoma and EHA overviewПодробнее

Advances in Lymphoma Clinical Trials (Podcast)Подробнее

CAR T-Cell Therapy Clinical TrialsПодробнее

Clinical trials and novel agents under investigation in T-cell lymphomaПодробнее

Understanding Clinical Trials for Cutaneous LymphomaПодробнее

Clinical Trials and Latest Research for Cutaneous T-Cell Lymphoma (CTCL)Подробнее

Clinical Trials for CTCL and How to Find ThemПодробнее

Dr. Horwitz on Updates in T-Cell Lymphoma TreatmentПодробнее